Androgen replacement in adolescents and young women with hypopituitarism

Journal of Pediatric Endocrinology and Metabolism

Volumn 18, Issue 4, 2005, Pages 355-362

  Bilger, Marie ^a   Speraw, Susan ^b   LaFranchi, Stephan H ^a   Hanna, Cheryl E ^a  

^a OREGON HEALTH AND SCIENCE UNIVERSITY   (United States)

^b UNIVERSITY OF TENNESSEE   (United States)

Author keywords

Adrenal insufficiency; Androgen deficiency; Dehydroepiandrosterone replacement; Panhypopituitarism

Indexed keywords

ANDROGEN; CORTICOTROPIN; GROWTH HORMONE; PLACEBO; PRASTERONE; THYROTROPIN; VASOPRESSIN;

ADOLESCENT; ADRENAL INSUFFICIENCY; ADULT; ANDROGEN DEFICIENCY; ANDROGEN THERAPY; ARTICLE; BODY COMPOSITION; BODY FAT; BONE DENSITY; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CORTICOTROPIN BLOOD LEVEL; CORTICOTROPIN DEFICIENCY; CROSSOVER PROCEDURE; DOUBLE BLIND PROCEDURE; DUAL ENERGY X RAY ABSORPTIOMETRY; EXERCISE; FEMALE; FOLLOW UP; GONADOTROPIN BLOOD LEVEL; GONADOTROPIN DEFICIENCY; GROWTH HORMONE BLOOD LEVEL; GROWTH HORMONE DEFICIENCY; HEALTH SURVEY; HUMAN; HYPOPITUITARISM; LIFE SATISFACTION; LUMBAR VERTEBRA; MUSCLE STRENGTH; OXYGEN CONSUMPTION; PSYCHOLOGIC TEST; RANDOMIZED CONTROLLED TRIAL; RATING SCALE; STATISTICAL SIGNIFICANCE; THYROTROPIN BLOOD LEVEL; TREATMENT OUTCOME; VASOPRESSIN BLOOD LEVEL;

EID: 17144402583     PISSN: 0334018X     EISSN: None     Source Type: Journal    
DOI: 10.1515/JPEM.2005.18.4.355     Document Type: Article

References (26)

1. Ilondo MM, Vanderschueren-Lodeweyckx M, Vlietinck R, Pizarro M, Malvaux P, Eggermont E, Eeckels R. Plasma androgens in children and adolescents-part II. A longitudinal study in patients with hypopituitarism. Horm Res 1982; 16: 78-95.
2. Miller KK, Sesmilo G, Schiller A, Schoenfeld D, Burton S, Klibanski A. Androgen deficiency in women with hypopituitarism. J Clin Endocrinol Metab 2001; 86: 561-567.
3. Dacou-Voutetakis C, Kakourou T. Treatment of atrichia pubis in adolescent girls with pituitary dwarfism. J Pediatr 1996; 128: 284-285.
4. Wit JM, Langenhorst VJ, Jansen M, Oostdijk W, van Doorn J. Dehydroepiandrosterone sulfate treatment for atrichia pubis. Horm Res 2001; 56: 134-139.
5. Allolio B, Arlt W. DHEA treatment: myth or reality? Trends Endocrinol Metab 2002; 13: 288-294.
6. Burger HG. Androgen production in women. Fertil Steril 2002; 77: S3-5.
7. Arlt W, Callies F, van Vlijmen JC, Koehler I, Reinske M, Bidlingmaier M, Huebler D, Oettel M, Schulte HM, Allolio B. Dehydroepiandrosterone (DHEA) replacement in women with adrenal insufficiency. N Engl J Med 1999; 341: 1013-1020.
8. Hunt PJ, Gurnell EM, Huppert FA, Richards C, Prevost AT, Wass JAH, Herbert J, Chatterjee VK. Improvement in mood and fatigue after dehydroepiandrosterone replacement in Addison's disease in a randomized, double blind trial. J Clin Endocrinol Metab 2000; 85: 4650-4656.
9. Johannsson G, Burman P, Wiren L, Engstrom BE, Nilsson AG, Ottosson M, Jonsson B, Bengtsson BA, Karlsson FA. Low dose dehyroepiandrosterone affects behavior in hypopituitary androgen-deficient women: a placebo controlled trial. J Clin Endocrinol Metab 2002; 87: 2046-2052.
10. Lovas K, Gebre-Medhin G, Trovik TS, Fougner KJ, Uhlving S, Nedrebo BJ, Myking OL, Kampe O. Replacement of dehydroepiandrosterone in adrenal failure: no benefit for subjective health status and sexuality in a 9 month, randomized, parallel group clinical trial. J Clin Endocrinol Metab 2003; 88: 1112-1118.
11. Gordon CM, Grace E, Emans SJ, Feldman HA, Goodman E, Becker KA, Rosen CJ, Gundberg CM, LeBoff MS. Effects of oral dehydroepiandrosterone on bone density in young women with anorexia nervosa: a randomized trial. J Clin Endocrinol Metab 2002; 87: 4935-4941.
12. Hintz RL. Confirming the diagnosis of growth hormone deficiency (GHD) and transitioning the care of patients with childhood-onset GHD. J Pediatr Endocrinol Metab 2003; 16 (Suppl 3): 631-635.
13. Ware JE Jr, Sherbourne CD. The MOS 36-item short-form health survey (SF-36). I. Conceptual framework and item selection. Med Care 1992; 30: 473-483.
14. Chubon RA. Development of a quality-of-life rating scale for use in health-care evaluation. Eval Health Prof 1987; 10: 186-200.
15. Beck AT, Steer RA, Garbin MG. Psychometric properties of the Beck Depression Inventory: twenty-five years of evaluation. Clin Psychol Rev 1988; 8: 77-100.
16. Dupuy HJ. The Psychological Well-Being (PGWB) index. In: NK Wenger, ed. Assessment of Quality of Life in Clinical Trials of Cardiovascular Therapies, New York: Le Jacq Publishing Inc., 1984; 170-183.
17. Melshior CL, Ritzmann RF. Dehydroepiandrosterone is an anxiolytic in mice on the plus maze. Pharmacol Biochem Behav 1994; 47: 437-441.
18. Roberts E, Bologa L, Flood JF, Smith GE. Effects of dehydroepiandrosterone and its sulfate on brain tissue in culture and on memory in mice. Brain Res 1987; 406: 357-362.
19. Abadie JM, Wright B, Correa G, Browne ES, Porter JR, Svec F. Effect of dehydroepiandrosterone on neurotransmitter levels and appetite regulation of the obese Zucker rat: the Obesity Research Program. Diabetes 1993; 42: 662-669.
20. Wolkowitz OM, Reus VI, Keebler A, Nelson N, Friedland M, Brizendine L, Roberts E. Double-blind treatment of major depression with dehydroepiandrosterone. Am J Psychiatry 1999; 156: 646-649.
21. Labrie F. Intracrinology. Mol Cell Endocrinol 1991; 78: C113-118.
22. Orwall ES, Stribrska L, Ramsey EE, Keenan EJ. Androgen receptors in osteoblast-like cell lines. Calcif Tissue Int 1991; 49: 183-187.
23. Steinberg KK, Freni-Titulaer LW, DePuey EG, Miller DT, Sgoutas DS, Coralli CH, Phillips DL, Rogers TN, Clark RV. Sex steroids and bone density in premenopausal and perimenopausal women. J Clin Endocrinol Metab 1989; 69: 533-539.
24. Devogelaer JP, De Cooman S, Nagant de Deuxchaisnes C. Low bone mass in hypogonadal males. Effect of testosterone substitution therapy, a densitometric study. Maturitas 1992; 15: 17-23.
25. Davis SR, McCloud P, Strauss BJ, Burger H. Testosterone enhances estradiol's effect on postmenopausal bone density and sexuality. Maturitas 1995; 21: 227-236.
26. Parasrampuria J, Schwartz K, Petesch R. Quality control of dehydroepiandrosterone dietary supplement products [letter]. JAMA 1998; 280: 1565.